Seeing Is Believing
with an average price target of $4.41. This is a potential upside of $4.41 (0%) from yesterday's end of day stock price of $0.
Kindred Biosciences's activity chart (see below) currently has 21 price targets and 16 ratings on display.
Analysts average stock forecasts to be materialized ratio is 44.17% with an average time for these price targets to be met of 189.88 days.
Most recent stock forecast was given by BEN HAYNOR from ALLIANCE GLOBAL PARTNERS on 23-Aug-2021. First documented stock forecast 17-Nov-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$15.25
3 years 3 months 8 days ago
(23-Aug-2021)
2/4 (50%)
$10.95 (254.65%)
332
Hold
3 years 5 months 14 days ago
(17-Jun-2021)
2/4 (50%)
$4.96 (35.33%)
30
Hold
$9
$-0.25 (-2.70%)
$12
3 years 5 months 14 days ago
(17-Jun-2021)
0/4 (0%)
$6.82 (88.53%)
Hold
$9.25
$11
3 years 5 months 15 days ago
(16-Jun-2021)
1/5 (20%)
$0.02 (0.22%)
69
Hold
$9
$-0.25 (-2.70%)
3 years 5 months 15 days ago
(16-Jun-2021)
0/2 (0%)
$3.3 (36.00%)
What is KIN (Kindred Biosciences) average time for price targets to be met?
Which analyst has the current highest performing score on KIN (Kindred Biosciences) with a proven track record?
Which analyst has the current lower performing score on KIN (Kindred Biosciences) with a proven track record?
Which analyst has the most public recommendations on KIN (Kindred Biosciences)?
Which analyst is the currently most bullish on KIN (Kindred Biosciences)?
Which analyst is the currently most reserved on KIN (Kindred Biosciences)?